GPT and hepatocellular carcinoma: Numerous studies have shown that one-third to one-half of treatment-naïve CHB patients with normal alanine transaminase (ALT) levels may still experience substantial inflammation or fibrosis and may even have increased risks of HCC and death/transplantation [4].